Oura and Dexcom join forces to transform metabolic health
Longevity Technology - 21-Nov-2024Integrated glucose monitoring and wearable insights offer a personalized approach to health tracking
Join the club for FREE to access the whole archive and other member benefits.
Integrated glucose monitoring and wearable insights offer a personalized approach to health tracking
Funding strengthens their capacity to address unmet needs in immune-related diseases
A $70m fund takes bold risks to validate ground-breaking ideas and reshape biotech innovation
Their technology reduces costs and accelerates drug development by six months
The funding enables industrial production, clinical trials, and patent filing
A science-backed approach to healthier, younger-looking skin
NVIDIA will support Genesis in optimizing neural networks for 3D data handling
Seven board members recently resigned after a failed buyout offer
Through the NHS, Open Bionics provides its prosthetics to eligible patients across the UK
Projects include Alzheimer’s research, brain implants, and digital brain modeling for safer AI
Experts highlight the risks involved in trusting private companies with genetic data
Initiatives like The Human Phenotype project aim to improve disease diagnostics and predictions
Experts highlight privacy risks for families and advocate stricter controls on DNA data use
New funding powers AI-driven implants to revolutionize neurological care
Aliada’s BBB technology aims to transform CNS drug delivery
New funding accelerates AI advancements for precision medicine
Together, they aim to provide pharmaceutical companies with precise tools for drug development
They aim to use AI-driven capsid design for delivery for complex treatments
Funding speeds U.S. entry and scales production as Orthocell advances global expansion
A competition tests top biological clocks to find the best health predictors
Their partnership with Calico focuses on age-related disease treatments
Their Polaris system aims to improve cataract removal precision and consistency
Clinical study showed its accuracy, aiming to replace invasive methods like PET scans
They use stem cell technology to regenerate the thymus and aim to slow its natural decline
Shift aims to treat diseases like heart issues and arthritis by addressing aging’s root causes
New proteasome-activating drugs aim to tackle neurodegenerative diseases and extend healthy lifespan
Targeted cell depletion offers a transformative strategy to treat diseases at their root
Clock.bio secures funding to explore genetic pathways for enhancing healthspan
New funding accelerates the development of a novel neutrophil-based solid tumour treatment
Using AI and biology to speed up drug discovery for healthier ageing
Support from Didier Coeurnelle enables groundbreaking longevity studies to advance
AI-powered handheld system aims to expand robotic precision to routine healthcare procedure
Revolutionizing chronic disease detection through innovative retinal imaging technology
Biotech advances human lactoferrin for better health and longevity
Innovative partnerships aim to develop groundbreaking therapeutics for age-related diseases in cats
The startup leverages its TFome™ platform for rapid and efficient iPSC programming
Their lead treatment, EA-2353, shows promising safety results for retinitis pigmentosa
ONL pushes forward with innovative treatment to slow vision loss in dry AMD
Early clinical trials showed safety and effectiveness, with more trials planned for 2025
An AI model set to transform drug discovery through cutting-edge molecular predictions
This lab-grown blood could solve donor shortages and help with frequent transfusions
Their aim is to improve preventive health with personalised solutions
Innovative platform accelerates drug discovery for metabolic diseases and more
Cutting-edge AI and laser technology will scale production of personalized regenerative medicines
Boosting fat loss and preserving muscle with cutting-edge mitochondrial therapy
Xenotransplantation biotech advances groundbreaking pig kidney transplants
Biotech firm Bioage plans public debut as it advances promising obesity treatments
German startup decodes the dark genome, advancing precision medicine
Revolutionary approach to reverse ageing process with CRISPR gene editing technology
A promising one-time treatment approach for arrhythmogenic cardiomyopathy
Transforming healthcare with non-invasive, drug-free technology
The funds will help expand their market reach, particularly into the US
Extending healthspan and lifespan through personalized, preventive care
Pooling strengths to rival a competing therapy for Niemann-Pick type c1
New funding propels innovative mitophagy-inducing lead compound into clinical trials targeting Alzheimer’s and Parkinson’s
Peter Diamandis shares insights on living longer through tech innovation
Large investments continue, but human research outcomes remain uncertain
New treatment aims to reactivate dormant hair follicles, offering hope for those affected by pattern baldness
How lifespan-extending drugs could shape the next biotech boom
This merger aims to deliver quicker results and generate substantial revenue
Approach is based on research from UCSF and could transform how diseases are treated
AI could cut preclinical drug development time by half, but rigorous trials are crucial
Funding will primarily be used to advance therapies focused on muscle growth
Funding fuels clinical trials of a lead compound, offering hope for liver disease patients
Company is particularly focusing on less invasive treatments for dry AMD and XLRP
Company is seeking $20M to expand its trial in New Zealand and the U.S
This could eventually lead to new ways to prevent and treat age-related diseases
Public support can play a crucial role in accelerating progress
Canadian company secures $8M to unlock future regenerative therapies through cryopreservation
Targeting prostaglandin biology could lead to breakthrough parkinson’s therapies
Company aims to improve protein production in genetic medicine
Company is developing therapies for Alzheimer's, Parkinson's, and Rett syndrome
Company's approach involves detecting, correcting, and eliminating damaged cells
This technology could potentially improve the quality of life for many older individuals
Programmable mRNA tech promise precise & safe treatment for disease and age-related conditions
Company is aiming to increase accessibility and affordability
Leveraging robotics and machine learning to design precise cancer treatments with minimal side effects
Their test, MyPhenome, identifies different types of obesity to tailor treatment plans
Technology aims to make animal studies more efficient, affordable, and humane
AI-powered platform predicts drugs for age-related diseases with 80% accuracy
AI-powered protein design models to transform medicine with next-gen therapeutics
Potentially leading to breakthroughs in managing chronic diseases
Technology promises faster identification of molecules for disease treatment
Longevity.Technology releases its annual longevity investment report 2023
Up to $2.5m per project to contribute to cutting-edge research in the field of ageing biology and geroscience
Funding fuels R&D, and collaboration focus on improving diagnosis and treatment options
The company remains focused on its independent cancer drug development
This investment supports the development of innovative pill-based therapies that use healthy gut bacteria
Company aims to target age-related diseases and liver disease NASH
Funds to advance compounds that target mTORC1 pathway for treating rare and age-related conditions
Personalized bioprints for affordable and more accessible transplants in the near future
Company will use machine learning and gut health science to create custom solutions
Company aims to revolutionize preventative healthcare using health tracking system
Company's innovative "liquid cornea" technology shows promise in restoring vision
Developing senotherapeutics to target cellular senescence and treat age-related diseases
Already over 200 organisations have pre-registered - this is going to be exciting to follow
Secures $47 million to advance its robotic innovation in soft tissue surgeries
Braingaze to develop apps for ADHD, autism and alzheimer's using eye-tracking technology
Accessible only for some: minimum of US$10,000 to invest in longevity breakthroughs
iPSC-based therapy set for phase 1 trials to replace lost neurons and modify disease course
Non-viral approach promises long-lasting treatment for AMD patients
Investment fuels its blood-brain barrier-crossing tech for better drug delivery
Its Y100 technology combats hair loss and potentially other age-related issues
Symani's wristed instruments bring steady hands and big ambitions to microsurgery
Unlocking a new era of comprehensive disease insights and treatment strategies
This powerful AI could transform how we approach disease research
Company aims to transform healthcare by using cutting-edge sugar-based diagnostics
All-natural ingredients to positively impact health and mental wellbeing
Their main drug, azelaprag, is like a pill that mimics the benefits of exercise
Aims to develop telomere-based therapies for age-related inflammatory diseases
Pi's accuracy might save healthcare costs and free up resources
They plan to offer quick full-body scans for $500 in a few years
This collaboration aims to unlock the secrets of ageing and develop new therapies
Their treatment uses implanted cells to calm brain activity and repair damaged networks
Early studies look promising, and the company plans to launch its product soon
They picked RJVA-001, a gene therapy, as their first clinical candidate
Financial struggles continue, but CEO Anne Wojcicki remains optimistic
Company aims to shift medicine's focus from illness treatment to proactive health optimization
It is already used in 15 countries to detect atrial fibrillation and heart failure
Open to: Individuals, teams, professionals, and anyone with an innovative idea
This £4.2M boost will help them offer this tech more widely in Europe and US
The test involves taking a cheek swab and getting a personalised report
Tiny robots made of DNA can now deliver your medicine straight to the cells
Vesper's main drug, called VES001, is a pill that can reach the brain directly
Report suggests that our focus needs to move from lifespan to healthspan
Sano's software pinpoints the perfect treatment match for each patient
New therapies combat age-related brain diseases by restoring blood vessel heath
Company plans to bring their revolutionary Mitopure technology to the world
Their AlphaFold engine models proteins could lead to faster and more effective treatments
Eli Lilly and Novartis invest in cutting-edge AI to accelerate the search for life-saving treatments
This, they claim, is safer and more precise than traditional gene editing methods
Fauna's AI platform explores animal data to unlock breakthroughs in weight management
Tome Biosciences secures $213m to advance next-gen gene editing
Silicon Valley startup uses personalized data and AI twin to reverse type 2 diabetes and obesity
The method measures increased fluctuations in methylation levels called "noise"
Company's drug targets the root cause of diseases like Duchenne and COPD
Mitophagy-boosting drug candidate VNA-318 preps for clinical trials
AI-powered data platform empowers early disease detection and proactive care at home
The drugs target obesity, diabetes, and potentially, human longevity
10 years of functional age-reversal in 65-80 year olds within the next 7 years... bring it on!!!
Offers over 20 innovative organ models for realistic testing and collaborating
A step towards empowering women for better health and quality of life
Company's pipeline targets inflammation, promote healing, and restore quality of life
Company's fasting mimicking technology could revolutionise ageing
Using AI to screen natural compounds and create novel longevity products
A $20,000 prize for innovative approaches to increase longevity sector funding
Company's "cell-free DNA platform" can detect unexplored cell-free DNA fragments
The app helps users boost their energy levels and feel more alive
The novel drugs called molecular gates eliminate disease-causing proteins
Ring-type blood pressure monitor to revolutionise hypertension management
Nanotech's nanoparticles could extend healthspan for everyone
Michelle Donelan praises the AI investment, stating it will transform healthcare
Company's innovative approach could revolutionise organ transplantation
Government funding to fuel innovation and growth in the life science sector.
Unlocking the secrets of cancer and genetic diseases with nanopore sequencing
Company's quest to decode ageing and develop novel therapies gains momentum
CST-3056 targets cognitive decline in Alzheimer’s with a phase I trial in 2024
Platform decodes brain signals, enabling thousands of applications
The event's success fuels optimism for future longevity awareness events
Aims to reach an annual production capacity of 500 artificial hearts
GC will design and deliver mRNA constructs; Immetas will identify therapeutic targets
Aims for Alzheimer's drugs that target brain's predominant cells, astrocytes
Enrollment paused, but $1.5 million secured from new partnership
Technology could make mRNA vaccines and therapeutics more effective and safer
MUSA-3, a next-gen microsurgical robot, boosts surgical precision and versatility
Technology could revolutionise the treatment of degenerative diseases
Company's LINQ platform streamlines drug development for scientists
This may improve immune function for those with thymus disorders and immune decline
Implant continuously monitors cancer and adjusts immunotherapy dose in real time
Investing in the next generation of longevity biotech companies
Company's INDUCE-seq platform could revolutionise cell & gene therapy efficiency
Technology can successfully measure muscle activity, brain waves, and more
Lead program targets TRPV4, an ion channel that is involved in several diseases
Lead antibody shows promising preclinical data & is set for clinical development
Developing "biological software" for effective and affordable mRNA drug design
A single dose of mRNA therapy could rewind ageing and extend lifespan
Multistem aims to boost organ preservation and transplant success
Pig plasma therapy could reverse aging in humans
Funds to help AI-discovered drugs enter clinical trials and expand its pipeline
FDA approves Neuralink's brain implant, patients can now sign up for trials
By editing RNA instead of DNA, the company aims to treat multiple undruggable genetic diseases safely
Planning to test its therapies in dogs next year, with human treatments expected in the near future
VitalOne reports 50 lab tests in just 20 minutes and improves accessibility for clinicians & patients
Innovative BIOVANCE single- and three-layer products for ocular surface disease treatment & surgical support
Lab-grade kit that measures 17 biomarkers of health & fitness with a finger-prick blood sample
AI-powered research platform to accelerate the processes in drug discovery and development
NBTXR3 to enhance the effect of immunotherapies; plans for phase 3 trial in head and neck cancer
Highly accurate enzyme-based approach to advance the ability to read, write and manipulate DNA
Ground-breaking technology to advance the development of a bio-engineered thymus & lung disease treatments
Aims to spread its life-enhancing solutions (including collagen booster) further across the globe
Recombinant human collagen based fillers help advance the field regenerative aesthetics
Novel recombinant protein to manufacture biologically fit cells by safely lengthening telomeres
Plans to leverage exclusive Attobody nanobody platform to develop innovative treatments in immunology and oncology
Biotech leverages insights from immunology and cardiology, aiming to dissolve arterial plaques with their flagship asset, BRB-002
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Innovative technology combines synthetic biology, genomics, and machine learning to transform the way diseases are diagnosed and treated
Strategic investment aimed at harnessing the power of collaborative innovation and AI in the pursuit of groundbreaking therapeutics
Urges individuals with resources and a desire to contribute positively to humanity to invest in the longevity industry
Reprogramming the epigenetics of a cell could reverse a significant amount of the functional decline that we see with age
VitaDAO has already funded 17 projects - including research areas not supported by traditional government agencies
Will use its drug discovery platform to further development of lead compound, IA101
Stealth development now public and aiming for multi-million dollar turnover by end of year
Apply now to showcase your translational longevity research and win CHF 50,000
Nanorobots make the process cost-efficient and fast, with same level of accuracy compared to tradition method
Aims to extend human healthspan and promote impactful lifestyle changes
Looking to invest in the longevity industry? Stakes from $100 available on Wefunder platform
Tissue-specific gene therapies & rejuvenating factors to extend lifespan and combat age-related diseases
Lower the metabolic rate and body heat, longer the lifespan, but has double-edged sword nature to it
Thymmune aims at developing therapies to treat several autoimmune diseases and organ transplant tolerance
Epigenetic medicine approach avoids the pitfalls of traditional CRISPR method of gene editing
No drug candidates yet, but great to see investors willing to support a broad attack on ageing
A revolutionary approach in regenerative medicine that could improve quality of life in patients
Mitochondria dysfunction is linked to several ageing-related diseases, including neurodegeneration, so a big potential market
The researchers will not only focus on CVD or cellular aging but the optimal point of intervention
MicroLED tech could revolutionize the display industry but is still in its early stages of development
New antibody approach aims to slow or halt Huntington’s disease progression
Plan is to build a generic platform then work with major pharma companies to take them to market
Next-generation proteomics technology to accelerate drug discovery and development
Funding will accelerate development of autophagy-based treatments for challenging diseases
Advances in AI is great, but this sort of automation is what will create the data it needs to find new longevity drugs
Its a fully integrated approach for developing biologics for chronic and age-related diseases
Kizoo is focused on rejuvenation biotech so it must see potential in normalizing CDC42 activity
There is a strange overlap in interests between crypto people and longevists - and long may that benefit the industry!
Cyberdontics-robot cuts the tooth and fabricates a prosthetic at the same time-efficacy and speed
Cell therapies aiming not only to correct the genetic defect but also repair and heal the muscle cells
Aims to treat age-related diseases using advanced cellular reprogramming technologies
Cleara’s novel FOXO4-based treatment approach-ability to eliminate biomarker-positive scarred cells
Founders are excited to find the impact when software intersects science
Pretzel targets genome correction, genome expression modulation and mitochondrial quality control
New firm launched by 3D Systems to advance drug discovery and testing process
Ichor Life Sciences leads the investment to advance anti-glycation therapies
They aim to identify aging pathways and develop new drugs and biomarkers
Let's hope their research is either successful for the company or its successors
VascVersa is committed to regenerative medicine for people suffering from ischaemic diseases
ForSight Robotics main goal is to democratize sophisticated eye treatment procedures globally
Effectively communicating to investors will translate an ideology into a social benefit
The acquisition strengthens the Fujirebio Neuro Center, making it a leading hub in diagnostics
Also announces move to Buck Institute for Research on Aging
Metabolites induce autophagy, stimulate cellular regeneration for healthy ageing
Developing a software platform that uses quantum computers to accelerate the discovery of new drugs
Funding might allow RNA-based rejuvenation tech to enter ex vivo lab tests
Considering funding a $100 million age reversal X Prize and the TAME(metformin) trial
Big data combined with laboratory automation - the pace of drug discovery is about to take off!
Cost-efficient whole genome-sequencing at a price of $1/Gb using NGS
Treatment options for diseases of aging - from the makers of metabolic switch
Targeting age-related diseases, the company's pre-clinical compounds to progress to the clinic
Aeson could prolong lives of patients awaiting a human heart transplant
Bioengineered implanatable tissues can repair or replace diseases organs
Another company enters the cellular reprogramming race - hopefully at least one will cross the finishing line
mRNA technology-reset aging to extend health span and improve quality of life
Initially targeting stiffened arteries in cardiovascular disease, this could have wider implications
$180M fund will support research on cellular reprogramming, autophagy & plasma-inspired therapeutics
Innovative tech to make self-administered therapies easier and more accessible
The approach may make testing more accessible for those without specialist healthcare access
Funds will be used to develop enzymes that repair collagen and reverse ageing or disease
Different flavours of rapalogs targeting different age-related conditions
And by longevity it means "substantially increase health span or life span" - apply now!
Appears to be ahead in the race as already started human trials
dNovo converts any cell to hair stem cells, and have already grown hair in mice
Tailoring strategies to eliminate bad cells in age-related diseases
Fast, cheap and plentiful iPSCs will be needed for clinical trials and new treatments
Huge backing that cellular reprogramming can have a significant impact on health and ageing
Funding will ensure the development of a new immunotherapy for age-related diseases
Highlights some nuances when investing in the longevity industry
Seeking funds to develop gene therapies that target ageing in humans and dogs
Invests $82 million in research platforms, aiming to prevent or reverse age-related diseases
Funds to develop regenerative therapies for retinitis pigmentosa and advanced age-related macular degeneration
Aiming to invest in 15-20 biotech firms, including Cambrian Biopharma, to target drivers of ageing
Aims to extend healthspan and cure ageing with affordable epigenetic therapies
Raised $18 million Series A funding to speed up ageing research
DKG subsidiary to introduce biomarker-driven Longevity risk mitigation and intervention support
Mentorship and funding support for biotech innovators tackling ageing
Biotech experts back 1E, believing it can transform medical treatments
Raised $46 million to commercialize and advance robot-assisted surgical technology
Invests in early stage companies that target root causes of age-related diseases
Raised $2.5 million to discover and sell life extension products directly to consumers
Novel business approach helps people to live longer with good health
Merger to improve remote health services and offer personalised treatment plans
From drug discovery to longevity insights, a startup reshapes age-related medicine
Leveraging systems pharmacology to streamline drug development and optimize therapeutic outcomes
Plans to invest in 10 start-ups - any of which could make a step towards longevity escape velocity
The foundation's mission is to make longevity medicine accessible to everyone - fantastic news!
Developing therapies to extend life in dogs, and further extending the research in humans
Funds to bring affordable and effective age-related therapies to the public
$40 million for clinical research, lead program-stroke recovery focuses GDF11
Developing painless tests to detect lung cancer, liver diseases, respiratory diseases, and gut health
Raised $440m to advance e-RNA based medicine for a wide range of diseases
By investigating self-healing mechanisms in animals, Fauna bio aims to cure human diseases.
Supports ageing research and advancing early-stage projects to phase 2 trials over the next decade
Both companies to continue with the diverse technologies and product development
Latvian based startup aims for cost-effective research studies, prioritizing study participants
The $2.2 billion deal will focus on immune-based therapies for neurodegenerative diseases
Connecting aspiring longevity founders with mentors to drive innovation in anti-ageing biotech
Synestia system, a point-of-care device to detect any pathogen in less than 30 minutes
New collab with Teva Pharmaceuticals to identify drug targets for various diseases
Convergence of genomic technologies and machine learning digitizes liver biology
Printing brains and transplantable organs to save and improve lives
Funds to help this digital health company take a leap in offering quality healthcare
Investigational therapy on old mice cleared senescent cells up to 70%, extending life by 20%
Patient-specific cell therapies under clinical trials for treating lung cancer and melanoma
PEARL: Participatory Evaluation of Aging with Rapamycin for Longevity
Kizoo Technology Ventures helps to bring rejuvenation therapies from lab to clinic
Modernizing life insurance to keep its customers healthy and alive
Edifice Health raises $12M to drive breakthroughs in ageing and inflammation
A 11-year long research in mice revealed 5 potential compounds to increase human longevity
The drugs also showed high safety in human tissue and animal studies
Funds to advance gene therapy for age-related macular degeneration & innovative delivery system
Huge database of wildlife gut microbiota could screen potential therapies within days
Funds to bring the experimental drug to trials; symbolizes booming regenerative niche
Giant leap towards developing transformative medicines powered by machine learning
Spin out company from University of Exeter step forward towards precision medicine for age-related diseases
Working on its first two companies at the moment, aiming at global expansion in the coming years
Advancing technologies for tissue and organ rejuvenation with seed funding from Kizoo
Accelerates clinical trial plans for its lead candidate Rlx-01 targeting age-related muscle failure
Despite challenges, many companies and clinical trials in longevity field are constantly evolving
Eos Advisory and Kineticos collab will help find treatment for incurable cancers
Medical Research Future Fund Grants AU $1M to progress vision processing software
New York-based biotech company with unique approaches to treat age-related diseases
Biotech startup to make stem-cell based therapies to extend and save lives
Good to have another cyronics provider in Europe
Trials on mitochondrial transfusion might help tackle many ageing diseases
Post-demo on rodents, researchers to begin brain-brain communication in humans
This treatment could help in cases of severe liver disease, like NASH
Instead of targeting specific hallmarks/pillars - they want to target ageing as a whole
Expert researchers to address antibiotic resistance with the £100m fund by Ineos
Raises a total of $2M dollars this year amidst the pandemic
Funding targets early-stage companies and postdoc researchers with unique ideas
Raised $11M funding which goes into trials and developing functional organs
Comprehensive review of companies' clinical and financial state of play
Tracks your blood glucose in real time - helps optimise diet and exercise
German Bionic raises $20M fund in Series A to develop its exoskeleton technology
Using machine learning, they plan to expand RNA therapy to treat various diseases
Lead therapies of BioAge to treat age related diseases enter phase 2 trials
I've just donated to help #UnlockLongevity - these are the experts and they need funding!
Collaboration leverages cutting-edge DNA-encoded library technology to target unmet medical needs
rGDF11 in clinic targets multiple age related disease therapies
Platform is designed to help pharmaceutical companies detect substances efficiently
Plan to integrate it with their FDA approved Monarch robotic surgical system
Key investors raise funding to support longevity sector
Taisho and Insilico collabs to identify novel targets for senolytic drugs
The company with $170 million private funding has invested in various life extension therapies
Marks new era in advancing screening and early diagnosis of cancer technology
Novel autophagy-based approaches target muscular dystrophy and other challenging diseases
General feeling that failures are bound to happen - but that their approaches can succeed
App that monitors both digital and biomedical markers, sets for launch in 2021
Insights can tell what you should and shouldn't do to improve your longevity status
Company has gathered support from investors to quickly lead therapies to clinic then market
New gene expression therapy for various targets, with clinical trial planned for 2021
Old cells will be more young and beautiful
New drug could become the best one to target and treat multiple tumours in the future
Profit from OS-1 could fund development of more products and clinical trials
"I would say that the science is now for this field" - I couldn't agree more
Biological clocks are a moving target so they'll need other researchers to corroborate their analysis
Many tech giants are competing to dominate the mass market for smart glasses
Most people (including me!) won't have enough money to attend, but it's good to see more interest in longevity investments
UK-based startup reprogramming stem cells to generate new cell therapies
Goal is to develop drugs that target epigenetic mechanisms associated with neurodegeneration
Using AI to automatically read data from research paper databases and assess users for 20 diseases
Calico creator is now investing on frontier technology, healthcare & lifescience
With a total of $11 million, more in vivo preclinical drug testing to be expected
He believes in the importance of boosting immunoresilience among elderly
Allowing developments on tech that will kill cancer based on their genetics
VCs are starting to recognise ageing as a problem with a massive business opportunity
The deal moves company forward to initiating phase 1 trials in non-Hodgkin lymphoma next year
To support human clinical trial of novel encapsulated cell therapy for hemophilia A
After a successful phase 1 trial of the CVN424 done one mice, the company started phase 2 studies
Will begin clinical trials after completing pre-clinical studies
Foundation of the new therapies mechanism is to access and control the compounds of CSF
UK residents can buy an AgeCurve sample kit and send a saliva sample
When some of these succeed in human trials even more money will pile in to fund further advances
An interesting collection of interviews and white-papers with industry leaders
Company claims its technology reverses decline of mitochondrial function in aging and disease
First-in-human trial demonstrates safety and brain-target engagement for TREM2 therapy
New hope for the 37.9 million people worldwide living with HIV/AIDS
Interesting articles and some useful investment opportunities
Their "robot scientist" EVA is set to transform protein-based therapeutics
EVA combines machine learning, robotic automation, and synthetic biology
Analyses a huge amount of data without the help of an artificial intelligence
From lab to clinic in 2 years instead of 10 would have a huge impact on health
Life extension technology will be expensive, so it'll create inequalities between poor, rich people
Edwards believes 20–30 years will be added to the average lifespan with none of the ageing diseases
Good summary of some major investments in life extension companies
There's a chance for at least one of these novel approaches might work
Advancing treatments for age-related diseases and healthy ageing
Drugs will need to work better than the free alternative - calorie restriction
BHB therapeutics develops treatment to mimic the effects of good diet
$16m raided, FoxBio partnership with Juvenescence, lots going on
Encouraging signs from big companies - more interviews to follow
Aiming for a market of billions of people, not just the richest
Targeting brain function to address Parkinson’s and Alzheimer’s at their core
Innovation is necessary to survive in the field of nanotechnology
Investigating ability of GDF11 to rejuvenate the body
Groundbreaking research biotechs performs aging research together for longevity
Advancing immune-based therapies for alzheimer’s and dementia
Antoxerene partners with Juvenescence to discover drugs that clear senescent cells
LyGenesis seeks to use a patient’s own lymph nodes as bioreactors to grow functioning ectopic organs
Their approach addresses enzyme deficiencies, aiming to expand treatments for neurodegeneration
Advancing mitochondrial research to tackle age-related decline and neurodegenerative diseases
All the money in the world to fight ageing and death
Alexander Burik sensibly advises caution about any new type of treatment
Will rebrand as Enochian and also move to Los Angeles
Relaunches as a clinical-stage company, with phase 1 clinical trials of lead compound for Alzheimer’s
Could a financial incentive help people push the boundaries of lifespan?